Loading…
IMCC
IM Cannabis Corp.
NASDAQ· Healthcare· Drug Manufacturers - Specialty & Generic· CUSIP 44969Q406
$3.41-13.45%Price as of Aug 29, 18:46 UTC · updated once a day, after the close
Key metrics
- Market cap
- $2.06M
- P/E
- —
- Forward P/E
- —
- P/B
- —
- Dividend yield
- —
- Payout
- —
- EPS
- -$76.08
- ROE
- —
- Profit margin
- -39.13%
- Revenue growth
- -40.20%
- Beta
- 2.11
- 52-week high
- $77.10
- 52-week low
- $2.58
History
How the company evolved, year by year. Revenue and debt come from the annual reports — for most companies, the 10-K filings with the SEC since 2009; dividends from the payments themselves.
The bars are a balance on the closing date; the lines are what happened during the year. Revenue above equity is ordinary, not an anomaly — it means the company turns its capital over more than once a year.
Investors holding this
Major managers that reported this stock in their latest 13F.
Price over time
▼ -99.9% over 5Y.
today you would have $0.45▼ -100.0%
Dividends reinvested, splits accounted for. Past prices say what happened, not what will.
Indicators, year by year
The last 4 closed years. Each multiple uses that year’s closing price and that year’s reported numbers — not today’s. The range is set by the annual reports on record.
| Indicator | Median | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Year-end price | $41.70 | $69.93 | $64.26 | $175.50 | |
| P/S | 4.0x | 4.5x | 4.0x | 2.9x | 4.1x |
| P/B | 9.9x | — | 41.2x | 9.9x | 9.8x |
| EPS | -$2.67 | -$4.51 | -$4.45 | -$161.88 | |
| Profit margin | -20.14% | -20.68% |
Fair price, seven ways
Seven formulas applied to what the company reported. None of them predicts a price — each answers what the stock would be worth if its assumption held. The assumption is printed next to every number, because it is the assumption that produces the result.
Earnings
—
This formula has no meaning here — usually a loss, negative cash flow, or a missing input.
Earnings
—
This formula has no meaning here — usually a loss, negative cash flow, or a missing input.
Earnings
—
This formula has no meaning here — usually a loss, negative cash flow, or a missing input.
Earnings
—
This formula has no meaning here — usually a loss, negative cash flow, or a missing input.
Cash flow
$10.78
Cash flow growing 5.0% a year for 10 years, discounted at 10%, then 2.5% forever.
Operating
—
This formula has no meaning here — usually a loss, negative cash flow, or a missing input.
Others in the same sector
Companies of similar size in Healthcare, for comparison. The columns are the same ones above, in the same order.
| Stock | Price | P/E | P/B | Dividend yield | ROE | Market cap |
|---|---|---|---|---|---|---|
| SHPHShuttle Pharmaceuticals Holdings, Inc. | $3.54 | 39.3x | 0.6x | — | -326.36% | $2.07M |
| SLXNSilexion Therapeutics Corp | $0.36 | — | 0.4x | — | — | $2.02M |
| AKANAkanda Corp | $3.89 | — | — | — | — | $2.1M |
| EDVAEndovia Health Sciences, Inc. | $0.31 |
About the company
IM Cannabis Corp. engages in importation, distribution and sale of medical cannabis products in Israel and Germany. It provides medical cannabis dried flowers; and full-spectrum cannabis extracts under the IMC, BLKMT, and LOT420 brands. The company serves medical patients. IM Cannabis Corp. was founded in 2008 and is headquartered in Vancouver, Canada.
- 44
- Vancouver, Canada
Company description provided by Yahoo Finance.